cirrusOCT: The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes

Sponsor
Prince of Songkla University (Other)
Overall Status
Completed
CT.gov ID
NCT01067482
Collaborator
(none)
80
1
5.9
13.5

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate performances of each parameters of spectral domain (Cirrus) optical coherence tomography for distinguishing between normal eyes, glaucoma suspect and glaucomatous eyes

Detailed Description

Aim to determine which parameter of cirrus OCT is best sensitivity and specificity for glaucoma detection

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Time Perspective:
Prospective
Official Title:
The Performances of Spectral Domain Optical Coherence Tomography for Distinguishing Between Normal Eyes, Glaucoma Suspect and Glaucomatous Eyes
Study Start Date :
Sep 1, 2009
Actual Primary Completion Date :
Mar 1, 2010
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Glaucoma patients

Glaucoma suspect group

Normal population

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • BCVA at least 20/60

    • refractive error +/- 5 D Or astig +/- 3 D

    • enrolled in 3 population group (glaucoma, glaucoma suspect or normal)

    Exclusion Criteria:
    • VA less than 20/60

    • marked RF error

    • previous ocular trauma or surgery

    • unreliable visual field

    • poor signal cirrus OCT (less than 7)

    • other causes of optic nerve or macular disease other than glaucoma

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Glaucoma unit , Department of Ophthalmology Faculty of Medicine Prince of Songkla University Hat-yai, Songkhla, Thailand. Thailand 90110

    Sponsors and Collaborators

    • Prince of Songkla University

    Investigators

    • Principal Investigator: Weerawat Kiddee, MD, Prince of Songkla University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01067482
    Other Study ID Numbers:
    • EC 52-336-02-1-2
    First Posted:
    Feb 11, 2010
    Last Update Posted:
    Mar 23, 2010
    Last Verified:
    Oct 1, 2009
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 23, 2010